Leading the Way in Patient Care - Aegate Partners Address the Challenge of Falsified Medicines Directive

CAMBRIDGE, England, February 24, 2015 /PRNewswire/ --

• Following the announcement in September of the Aegate Safe Medicine Partner Program, the network's inaugural symposium took place in Amsterdam  
• Aegate announces geographic expansion for the AegatePROTECT™ services for European Patient Medication Safety 
• Aegate announces value add services in co-operation with its Eco Partners 

Farmad has 1,036 active pharmacies using Aegate services, the following quotes from pharmacists confirm the trust they have in Aegate's messaging technology:

"Taking up your responsibility as a carer to the fullest, using recent and real time pharmaceutical information that can be shared easily with your colleagues free of charge, activating an automatic update in my system."

"In a hectic pharmacy nowadays, a pharmacist is always busy thinking about everything, so that information concerning patient security, that maximises your role as a personal adviser, is a definite help from which the patient undoubtedly will feel the benefit."

A further presentation by the general manager of APB Belgian Pharmaceutical Association reconfirmed Aegate's credibility within the platform.  The event clarified that Aegate's robust system architecture and ease of integration reassures that FMD implementation is indeed care-free. Aegate and its partners are prepared to meet these challenges easily and with no disruption to pharmaceutical services.

Workshops were also held to stimulate new and innovative ideas between Aegate and its partners - plans going forward will include new services development and other forward thinking initiatives proposed by Aegate partners.

Aegate CEO Mark De Simone concluded the meeting underlining the sense of urgency to prepare for and implement FMD requirements, Aegate as your partner will ensure success meeting this challenge - an Aegate Safe pharmacy is a safer pharmacy.

About Aegate 

With a documented history of some 3 billion medicines scanned to date with an average rate of 200k transactions per hour across 15k dispensing points, Aegate is the principal active market leader in medicines verification. Aegate's Reach, Assure and Protect services meets the needs of all stakeholders. Supported internationally by manufacturers and pharmacists alike, Aegate is a European company with offices in Belgium, Italy, Switzerland and the UK. Our mission is to protect patients from falsified, recalled or expired medicines.

We operate a highly secure real-time system to verify the authenticity of medicines. This operates seamlessly from manufacturer to pharmacy, and fully meets the requirements of European legislation for falsified medicines. The Aegate network also supports messaging services that provide additional information for the pharmacist at the point of dispense, such as regulatory or drug safety advice and patient education or adherence information.

For more information on Aegate, please visit http://www.aegate.com

Company Contact:
Graham Smith
Commercial Director Aegate Ltd
Cambridge Technology Centre
Melbourn SG8 6DP UK

T: +44-1763-268160
M: +44-7785-748970

W: http://www.aegate.com

SOURCE Aegate